This inventor holds 1 USPTO granted patent. Top assignee: The Wistar Institute. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: Alonzo Ross: Innovator in Neural Crest Disease Detection
Introduction
Alonzo Ross is a notable inventor based in Bensalem, Pennsylvania. He has made significant contributions to the field of medical diagnostics, particularly in the detection of neural crest diseases. His innovative work has led to the development of a unique diagnostic method that utilizes monoclonal antibodies.
Latest Patents
Alonzo Ross holds a patent for a diagnostic method for the detection of neural crest disease. This method is based on the discovery that nerve growth factor binds to a cell surface protein of human neural crest origin, which has a molecular weight of about 75,000 daltons. New monoclonal antibodies have been developed that specifically immunoprecipitate these receptor molecules and inhibit the binding of the hormone to the receptor. Notably, these antibodies exhibit significantly higher reactivity with primary and metastatic melanoma cell lines compared to melanocytes. This advancement is crucial for the histochemical detection of human neural crest disease.
Career Highlights
Alonzo Ross is affiliated with The Wistar Institute, where he has been instrumental in advancing research in his field. His work has not only contributed to scientific knowledge but has also paved the way for improved diagnostic techniques in medicine.
Collaborations
Alonzo has collaborated with esteemed colleagues such as Hilary Koprowski and Meenhard Herlyn. These partnerships have further enriched his research and expanded the impact of his innovations.
Conclusion
Alonzo Ross's contributions to the field of medical diagnostics, particularly through his patent for detecting neural crest disease, highlight his role as an innovator. His work continues to influence the landscape of medical research and diagnostics.